OMRON Healthcare Advances Blood Pressure Monitoring for AFib Detection with AI Technology and Donations
In a commendable move towards improving public health, OMRON Healthcare Co., based in Muko, Japan, has announced a significant initiative aimed at enhancing awareness of hypertension and atrial fibrillation (AFib) detection. The company is set to donate 4,000 blood pressure monitors equipped with advanced Intellisense AFib technology during the upcoming May Measurement Month (MMM), an annual global campaign dedicated to monitoring blood pressure.
This year's MMM runs from May 1 to July 31 and serves as a platform to educate the public about hypertension and the importance of regular monitoring. OMRON Healthcare has been a steadfast supporter of MMM since its inception in 2017, aiming to raise awareness about the risks associated with high blood pressure and AFib, a condition that can lead to severe cardiovascular events such as strokes.
The donated monitors will not only measure blood pressure but will also utilize the cutting-edge Intellisense AFib technology, which leverages artificial intelligence to facilitate the early detection of AFib. This initiative reflects OMRON’s broader commitment to advancing healthcare technologies that empower individuals to take charge of their health. With the alarming statistics indicating that hypertension is responsible for over 10 million deaths globally each year, the company's donation aims to alleviate this pressing health concern and promote proactive health management.
The need for such initiatives is underscored by data from the World Health Organization (WHO), which emphasizes that many individuals living with AFib remain asymptomatic. Alarmingly, approximately one in four individuals with AFib do not exhibit recognizable symptoms until the condition progresses. By offering devices capable of detecting potential AFib, OMRON aims to bridge this gap and educate users on their cardiovascular health.
OMRON Healthcare's efforts are not just confined to donations; they have a rich history of innovation and commitment to healthcare. Since its foundation, the company has sold over 350 million units of home-use blood pressure monitors globally, becoming a trusted name in health monitoring solutions. Their products are designed to allow both medical professionals and individuals to better manage conditions such as hypertension and AFib, thereby enhancing early detection and treatment strategies.
The MMM campaign will also offer visitors practical advice on dietary management and lifestyle changes aimed at controlling blood pressure. Some regions will provide additional assessments, enabling participants to gauge their risk of AFib through integrated ECG tests. With research indicating that the incidence of AFib triples in patients with hypertension, these efforts are essential in empowering communities to better understand their health risks.
Prof. Neil R. Poulter, the chief researcher and chair of MMM, highlighted the significance of regular blood pressure monitoring. He stated, 'Regular monitoring is an essential tool for identifying risks associated with hypertension and AFib. Through our collaboration and donation of monitors, we can facilitate early detection, improved treatment, and ultimately, save lives.'
OMRON's partnership with MMM has led to the donation of around 30,000 blood pressure monitors in 100 countries since the campaign began. As the upcoming MMM approaches, OMRON continues to advocate for community engagement in health monitoring and education.
For those interested in learning more about the May Measurement Month and its initiatives, further information can be found at www.maymeasure.org. This year's participation marks another critical step toward elevating the conversation around blood pressure health and AFib awareness globally.
In conclusion, OMRON Healthcare is not just donating devices; it is fostering a culture of health awareness and preventive care. As they continue to innovate and contribute to societal health, their commitment to improving lives through technology remains a beacon of progress. The integration of AI technology in healthcare monitoring presents an exciting future, where early detection and effective management can significantly reduce the burden of cardiovascular diseases.
This year's MMM runs from May 1 to July 31 and serves as a platform to educate the public about hypertension and the importance of regular monitoring. OMRON Healthcare has been a steadfast supporter of MMM since its inception in 2017, aiming to raise awareness about the risks associated with high blood pressure and AFib, a condition that can lead to severe cardiovascular events such as strokes.
The donated monitors will not only measure blood pressure but will also utilize the cutting-edge Intellisense AFib technology, which leverages artificial intelligence to facilitate the early detection of AFib. This initiative reflects OMRON’s broader commitment to advancing healthcare technologies that empower individuals to take charge of their health. With the alarming statistics indicating that hypertension is responsible for over 10 million deaths globally each year, the company's donation aims to alleviate this pressing health concern and promote proactive health management.
The need for such initiatives is underscored by data from the World Health Organization (WHO), which emphasizes that many individuals living with AFib remain asymptomatic. Alarmingly, approximately one in four individuals with AFib do not exhibit recognizable symptoms until the condition progresses. By offering devices capable of detecting potential AFib, OMRON aims to bridge this gap and educate users on their cardiovascular health.
OMRON Healthcare's efforts are not just confined to donations; they have a rich history of innovation and commitment to healthcare. Since its foundation, the company has sold over 350 million units of home-use blood pressure monitors globally, becoming a trusted name in health monitoring solutions. Their products are designed to allow both medical professionals and individuals to better manage conditions such as hypertension and AFib, thereby enhancing early detection and treatment strategies.
The MMM campaign will also offer visitors practical advice on dietary management and lifestyle changes aimed at controlling blood pressure. Some regions will provide additional assessments, enabling participants to gauge their risk of AFib through integrated ECG tests. With research indicating that the incidence of AFib triples in patients with hypertension, these efforts are essential in empowering communities to better understand their health risks.
Prof. Neil R. Poulter, the chief researcher and chair of MMM, highlighted the significance of regular blood pressure monitoring. He stated, 'Regular monitoring is an essential tool for identifying risks associated with hypertension and AFib. Through our collaboration and donation of monitors, we can facilitate early detection, improved treatment, and ultimately, save lives.'
OMRON's partnership with MMM has led to the donation of around 30,000 blood pressure monitors in 100 countries since the campaign began. As the upcoming MMM approaches, OMRON continues to advocate for community engagement in health monitoring and education.
For those interested in learning more about the May Measurement Month and its initiatives, further information can be found at www.maymeasure.org. This year's participation marks another critical step toward elevating the conversation around blood pressure health and AFib awareness globally.
In conclusion, OMRON Healthcare is not just donating devices; it is fostering a culture of health awareness and preventive care. As they continue to innovate and contribute to societal health, their commitment to improving lives through technology remains a beacon of progress. The integration of AI technology in healthcare monitoring presents an exciting future, where early detection and effective management can significantly reduce the burden of cardiovascular diseases.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.